<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="app1table7" position="float"><object-id pub-id-type="doi">10.7554/eLife.31486.040</object-id><label>Appendix 1&#8212;table 7.</label><caption><title>Sequence similarity comparison.</title><p>Frequencies of dipeptides (pairs of neighboring amino residues) were computed for phase-separating proteins and the human proteome, and enrichment was measured by the percentage of human proteins with lower frequency than found in a given sequence. The fifteen dipeptides enriched (&#8805;99%) in the most sequences within the phase separation test sets are shown in the table vs. enrichment values obtained for the phase separation training set and three experimentally verified proteins. Values in the top fifth percentile are shown in bold.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top">Protein <break/>Name</th><th colspan="15" valign="top">Dipeptide enrichment (Percentage of human proteome with lower frequency)</th></tr><tr><th valign="top">GV</th><th valign="top">VG</th><th valign="top">VP</th><th valign="top">PG</th><th valign="top">FG</th><th valign="top">RG</th><th valign="top">GR</th><th valign="top">GG</th><th valign="top">YG</th><th valign="top">GS</th><th valign="top">SG</th><th valign="top">GA</th><th valign="top">GF</th><th valign="top">GD</th><th valign="top">DS</th></tr></thead><tbody><tr><td colspan="16" valign="top">Training Set Proteins</td></tr><tr><td valign="top">Elastin</td><td valign="top"><bold>100</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>97</bold></td><td valign="top">31</td><td valign="top">32</td><td valign="top"><bold>99</bold></td><td valign="top"><bold>99</bold></td><td valign="top">20</td><td valign="top">20</td><td valign="top"><bold>100</bold></td><td valign="top">89</td><td valign="top">38</td><td valign="top">30</td></tr><tr><td valign="top">Nsp1</td><td valign="top">30</td><td valign="top">34</td><td valign="top">31</td><td valign="top">26</td><td valign="top"><bold>100</bold></td><td valign="top">31</td><td valign="top">30</td><td valign="top">75</td><td valign="top">52</td><td valign="top">90</td><td valign="top">38</td><td valign="top"><bold>99</bold></td><td valign="top">60</td><td valign="top">66</td><td valign="top">68</td></tr><tr><td valign="top">TIA1</td><td valign="top">73</td><td valign="top">75</td><td valign="top">46</td><td valign="top">26</td><td valign="top">86</td><td valign="top">31</td><td valign="top">86</td><td valign="top">77</td><td valign="top"><bold>99</bold></td><td valign="top">29</td><td valign="top">53</td><td valign="top">26</td><td valign="top">84</td><td valign="top">54</td><td valign="top">30</td></tr><tr><td valign="top">LAF1</td><td valign="top">30</td><td valign="top">78</td><td valign="top">65</td><td valign="top">29</td><td valign="top">67</td><td valign="top"><bold>99</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>100</bold></td><td valign="top">77</td><td valign="top">88</td><td valign="top"><bold>97</bold></td><td valign="top">65</td><td valign="top">78</td><td valign="top"><bold>97</bold></td><td valign="top">32</td></tr><tr><td valign="top">EIF4H</td><td valign="top">30</td><td valign="top">65</td><td valign="top">31</td><td valign="top">52</td><td valign="top"><bold>98</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>95</bold></td><td valign="top"><bold>99</bold></td><td valign="top">52</td><td valign="top"><bold>99</bold></td><td valign="top">42</td><td valign="top">79</td><td valign="top"><bold>99</bold></td><td valign="top"><bold>98</bold></td><td valign="top">89</td></tr><tr><td valign="top">Ddx3x</td><td valign="top">51</td><td valign="top">70</td><td valign="top">34</td><td valign="top">43</td><td valign="top">89</td><td valign="top"><bold>98</bold></td><td valign="top"><bold>97</bold></td><td valign="top"><bold>96</bold></td><td valign="top">93</td><td valign="top">93</td><td valign="top"><bold>95</bold></td><td valign="top">68</td><td valign="top"><bold>96</bold></td><td valign="top">59</td><td valign="top">78</td></tr><tr><td valign="top">hnRNPA1</td><td valign="top">30</td><td valign="top">55</td><td valign="top">31</td><td valign="top">44</td><td valign="top"><bold>100</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>98</bold></td><td valign="top">44</td><td valign="top"><bold>99</bold></td><td valign="top">60</td><td valign="top">79</td></tr><tr><td valign="top">DDX4</td><td valign="top">33</td><td valign="top">77</td><td valign="top">48</td><td valign="top">53</td><td valign="top"><bold>98</bold></td><td valign="top"><bold>96</bold></td><td valign="top">91</td><td valign="top">89</td><td valign="top">59</td><td valign="top">87</td><td valign="top"><bold>96</bold></td><td valign="top">29</td><td valign="top"><bold>98</bold></td><td valign="top"><bold>96</bold></td><td valign="top">45</td></tr><tr><td valign="top">FUS</td><td valign="top">30</td><td valign="top">31</td><td valign="top">31</td><td valign="top">83</td><td valign="top">78</td><td valign="top"><bold>100</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>98</bold></td><td valign="top"><bold>99</bold></td><td valign="top">33</td><td valign="top">93</td><td valign="top">91</td><td valign="top">57</td></tr><tr><td valign="top">EWS</td><td valign="top">52</td><td valign="top">31</td><td valign="top">35</td><td valign="top">97</td><td valign="top">51</td><td valign="top"><bold>100</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>100</bold></td><td valign="top">72</td><td valign="top">61</td><td valign="top">30</td><td valign="top"><bold>97</bold></td><td valign="top">91</td><td valign="top">48</td></tr><tr><td valign="top">TAF15</td><td valign="top">36</td><td valign="top">38</td><td valign="top">31</td><td valign="top">30</td><td valign="top">53</td><td valign="top"><bold>100</bold></td><td valign="top"><bold>99</bold></td><td valign="top"><bold>100</bold></td><td valign="top"><bold>100</bold></td><td valign="top">92</td><td valign="top"><bold>99</bold></td><td valign="top">26</td><td valign="top">71</td><td valign="top"><bold>100</bold></td><td valign="top">94</td></tr><tr><td colspan="16" valign="top">Experimentally Verified Proteins</td></tr><tr><td valign="top">FMR1</td><td valign="top">69</td><td valign="top">89</td><td valign="top">93</td><td valign="top">44</td><td valign="top">43</td><td valign="top"><bold>96</bold></td><td valign="top">94</td><td valign="top">83</td><td valign="top">62</td><td valign="top">62</td><td valign="top">34</td><td valign="top">70</td><td valign="top">48</td><td valign="top">41</td><td valign="top">67</td></tr><tr><td valign="top">SCAF pAP</td><td valign="top">75</td><td valign="top">50</td><td valign="top">89</td><td valign="top">91</td><td valign="top">43</td><td valign="top">49</td><td valign="top">73</td><td valign="top">97</td><td valign="top">75</td><td valign="top">92</td><td valign="top"><bold>96</bold></td><td valign="top"><bold>96</bold></td><td valign="top">40</td><td valign="top">36</td><td valign="top">44</td></tr><tr><td valign="top">Engrailed-2</td><td valign="top">30</td><td valign="top">31</td><td valign="top">31</td><td valign="top"><bold>97</bold></td><td valign="top">70</td><td valign="top">78</td><td valign="top">90</td><td valign="top"><bold>100</bold></td><td valign="top">52</td><td valign="top"><bold>99</bold></td><td valign="top">91</td><td valign="top"><bold>99</bold></td><td valign="top">40</td><td valign="top"><bold>95</bold></td><td valign="top"><bold>97</bold></td></tr></tbody></table></table-wrap>